This study is currently not recruiting participants.

Prospective incidence of persistent inflammatory immunosuppressed catabolic syndrome in the critically ill pediatric population

Investigating Persistent Inflammatory Syndrome in Children

Not Recruiting
100 years or below
All
Phase N/A
1 Location

Brief description of study.

The purpose of this study is to determine the incidence of persistent inflammatory, immunosuppressed, catabolic syndrome (PICS) in the pediatric population and associate the diagnosis of PICS to survival and time to return to baseline functional life.

Detailed description of study

The purpose of this study is to determine the incidence of persistent inflammatory, immunosuppressed, catabolic syndrome (PICS) in the pediatric population and associate the diagnosis of PICS to survival and time to return to baseline functional life.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: persistent inflammatory immunosuppressed catabolic syndrome
  • Age: 100 years or below
  • Gender: All

This study investigates persistent inflammatory, immunosuppressed, catabolic syndrome (PICS) in children. PICS is a condition where the body experiences ongoing inflammation, weakened immune response, and muscle breakdown. The study aims to find out how common PICS is in children and how it affects their survival and recovery to normal life.

Participants in the study will be monitored to see if they develop PICS and how it impacts their health. The study will involve regular health assessments to understand the relationship between PICS and recovery outcomes.

  • Who can participate: Eligibility criteria are not available at this time.
  • Study details: Participants will undergo health assessments to monitor for PICS and its effects. The study will track health outcomes to understand the impact of the condition.
Updated on 19 Feb 2024. Study ID: 1802247905

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team